What is the enterprise number of NXTLAB?

The enterprise number of NXTLAB is BE1006873757.

What is the address of NXTLAB?

The registered office of NXTLAB is located at Deltalaan 1, 8800 Roeselare.

When was NXTLAB founded?

NXTLAB was founded on 7 March 2024.

What is the main activity of NXTLAB?

The main activity of NXTLAB is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).

Does NXTLAB have a website?

No website is currently known for NXTLAB.

How much profit did NXTLAB make in 2025?

NXTLAB posted a profit after taxes of € 114,009 in financial year 2025.

What is the revenue of NXTLAB?

As a small company, NXTLAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 114,641.

Where can I find the annual accounts of NXTLAB?

NXTLAB files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.

Who are the directors of NXTLAB?

According to the 2025 annual accounts, the directors of NXTLAB are: Elmace BV, SA Artsen BV, An-Sofie Decavele BV, LabMed DDS BV, Inpe Farma BV, Frederik Van Hoecke BV, DR Inge Van Haute BV, Hilde Vanpoucke - Apotheker Klinisch Bioloog BV.

NXTLAB (Private Limited) - Roeselare (8800) - BE1006873757

Financials

Financial year 2025

Gross margin

€ 114,641

▲ 357% vs 2024

Profit

Growing

€ 114,009

▲ 438% vs 2024

Debts

High

€ 117,800

▲ 411% vs 2024

NXTLAB from Roeselare, company number BE1006873757, closed financial year 2025 with a result of € 114,009 after tax. For that financial year NXTLAB recorded a gross margin of € 114,641 and equity of € 1,389. Compared with financial year 2024, the result moved from € 21,181 to € 114,009. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What happened at NXTLAB?

What happened at NXTLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 22, 2026 New annual accounts for financial year 2025: profit of € 114,009 (▲ 438% vs 2024). Source: NBB ↗
Mar 7, 2024 New establishment in Roeselare. KBO
2024 Elmace BV became a director. NBB
2024 SA Artsen BV became a director. NBB
2024 An-Sofie Decavele BV became a director. NBB
2024 LabMed DDS BV became a director. NBB
2024 Inpe Farma BV became a director. NBB
2024 Frederik Van Hoecke BV became a director. NBB

In short

From € 21,181 profit in 2024 to € 114,009 profit in 2025.

Paid € 98 in corporate taxes since 2024.

Best year ever: 2025, with € 114,009 profit.

Paid out € 135,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at NXTLAB? We notify you, reason included.

Follow NXTLAB

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New

Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Elmace BV

SA Artsen BV

An-Sofie Decavele BV

LabMed DDS BV

NXTLAB

BOUCKAERT - MEKEIRELE

Behind NXTLAB are Elmace BV, SA Artsen BV, An-Sofie Decavele BV, LabMed DDS BV, Inpe Farma BV and Frederik Van Hoecke BV. The same people are also behind BOUCKAERT - MEKEIRELE.

See the full network in the app